Menu Close

Infection, Immunity, and Vaccine Seminar Program – 2008

12:00 p.m.

LSUHSC Campus, CSRB Room 563, 533 Bolivar St.

February 14 “Weak AIDS Vaccines, Safe AIDS Vaccines, and Some That May Even Work” Preston Marx, Ph.D.

Chair, Division of Microbiology and Immunology, Tulane National Primate Research Center, Tulane University Health Sciences Center, Covington, LA and Professor, Department of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University Health Sciences Center, New Orleans, LA.

February 25 “The Potential of Cyberinfrastructure for Complex Problem Solving in the Biomedical Sciences” Edward Seidel, Ph.D.

Chief Scientist, Louisiana Optical Network Initiative, Director of the Center for Computation & Technology, Floating Point Systems Professor, Departments of Physics & Astronomy and Computer Science, Louisiana State University, Baton Rouge, LA

February 28 “Ricin: Mechanisms of Toxicity and Protective Efficacy of Antibodies” Seth Pincus, M.D.

Director, Research Institute for Children, New Orleans, LA and Professor, Pediatrics and Microbiology, Immunology, & Parasitology, LSUHSC, New Orleans, LA

March 12 “Current Status of HIV Vaccine Development” Barney S. Graham, M.D., Ph.D.

Director of Clinical Studies, Dale and Betty Bumpers Vaccine Research Center (VRC), NIH, Bethesda, Maryland (TENTATIVE)

April 10 “Polymeric Nanoparticles: Novel Carriers for Vaccine Delivery” Tarun K. Mandal, Ph.D.

Professor of Pharmaceutics, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA

April 24 “HIV Neutralizing Antibodies: Obstacles in HIV Vaccine Development” James Robinson, M.D.

Professor, Section of Pediatric Infectious Diseases, Department of Pediatrics, Tulane Hospital for Children, New Orleans, LA

May 8 “Novel Adjuvants and Delivery Systems for Transdermal Immunization” John D. Clements, Ph.D

Professor and Chairman of Microbiology & Immunology, Tulane University HSC.

May 22 “The latest on host defense against mucosal yeast infections: It’s all about the site.” Paul Fidel, Ph.D.

Director, SLIIDR, Director, Center of Excellence in Oral & Craniofacial Biology, Associate Dean for Research, School of Dentistry, and Professor, Microbiology, Immunology, & Parasitology, LSUHSC, New Orleans, LA

June 12 “A new genetic vaccine for West Nile Virus.” K. Gus Kousoulas PhD

Director, Division of Biotechnology & Molecular Medicine LSU School of Veterinary Medicine

June 26 “Regulatory T cells and Infectious Disease” Barry Rouse, Ph.D.

Lindsay Young Distinguished Professor, UT Knoxville, TN

July 23 “Genetic Design and Manipulation of Salmonella Recombinant Vaccines.” Roy Curtiss III, Ph.D.

Director, The Biodesign Institute, Center for Infectious Diseases and Vaccinology Arizona State University

September 11 “The Human Immunology of Lassa Fever” Robert F. Garry, Jr. Ph.D.

Department of Microbiology & Immunology Tulane University Health Sciences Center

September 25 “Thoughts on the Origin of Microbial Virulence” Arturo Casadevall, M.D., Ph.D.

Professor, Department of Medicine (Infectious Diseases), Chair, Department of Microbiology & Immunology, Albert Einstein College of Medicine of Jeshiva University, New York, NY

October 9 “Modulation of the Host Response to Pneumocystis” Judd Shellito, M.D.

Lowenstein Professor of Medicine Chief, Section of Pulmonary/Critical Care Medicine LSU Health Sciences Center‐ New Orleans

October 23 “Poxvirus Tropism is Linked to Immune Evasion” Grant McFadden, Ph.D.

Professor, Department of Molecular Genetics & Microbiology College of Medicine, University of Florida

November 6 “Immunization Route Modulates the Quality of HIV-Specific Cytolytic T Cell Responses” Charani Ranasinghe, PhD

John Curtin School of Medical Research Australian National University

November 13 “Perturbation, resilience, and the human microbiome” David Relman, M.D.

Professor of Medicine (Infectious Diseases and Geographic Medicine) and of Microbiology and Immunology, Stanford University, Stanford, CA

December 11 “Mycoplasma genitalium: An Emerging Sexually Transmitted Pathogen” David Martin, M.D.

Chief, Section of Infectious Diseases Harry E. Dascomb Professor of Medicine Professor of Microbiology, LSU Health Sciences Center